Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AEHR TEST SYSTEMSAEHR · Entity 2640 | Director · President and CEO | October 12, 2026 | October 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AEHR TEST SYSTEMS
Report date October 12, 2026 · Filed October 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 191,108 |
Reported balance
After 2026-10-12 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-10-12 · Tax withholding · Disposed 2,675 · Balance 191,108 F1: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units and restricted shares. This does not represent a sale by the Reporting Person. F2: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 158,776 |
Reported balance
Holding disclosure · report date 2026-10-12 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 158,776 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units and restricted shares. This does not represent a sale by the Reporting Person.
F2: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 11, 2024 Filed Oct 15, 2024 18:35 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 2,346 | $16.02 | $37,582.92 |
DisclosureSEC source: 0001593968-24-001262 · primary_01.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 209,915 F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units and restricted shares. This does not represent a sale by the Reporting Person. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 20:42 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionNon-Qualified Option (right to buy) · Derivative | 3,338 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001593968-24-001204 · primary_01.xml · derivative · entry 5 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,338 shares Expires 2026-07-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional on forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 20:42 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionOption (right to buy) · Derivative | 16,251 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001593968-24-001204 · primary_01.xml · derivative · entry 4 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,251 shares Expires 2026-07-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional on forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 20:42 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 3,338 | $1.64 | $5,457.63 |
DisclosureSEC source: 0001593968-24-001204 · primary_01.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 212,261 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 20:42 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 16,251 | $1.64 | $26,570.39 |
DisclosureSEC source: 0001593968-24-001204 · primary_01.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 208,923 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 29, 2024 Filed Jul 30, 2024 01:10 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 563 | $18.54 | $10,438.02 |
DisclosureSEC source: 0001593968-24-001022 · primary_01.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,672 F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares. Read SEC document |
| July 14, 2024 Filed Jul 16, 2024 19:24 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 3,570 | $16.43 | $58,655.10 |
DisclosureSEC source: 0001593968-24-000991 · primary_01.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 193,235 F2 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units and restricted shares. This does not represent a sale by the Reporting Person. F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares. Read SEC document |
| July 13, 2024 Filed Jul 16, 2024 19:24 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 1,154 | $16.43 | $18,960.22 |
DisclosureSEC source: 0001593968-24-000991 · primary_01.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 196,805 F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person. Read SEC document |
| July 11, 2024 Filed Jul 12, 2024 01:12 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 920 | $15.11 | $13,901.20 |
DisclosureSEC source: 0001593968-24-000963 · primary_01.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,028 F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units and restricted shares. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares. Read SEC document |
| July 11, 2024 Filed Jul 15, 2024 22:21 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 63,931 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-24-000982 · primary_01.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,959 F1 · shares: One-sixteenth (1/16) of the total number of shares subject to the restricted stock unit awards shall become exercisable at the end of each three full calendar months following the date of this action, provided that such recipient is still employed by the corporation on such dates. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares. Read SEC document |
| April 29, 2024 Filed Apr 30, 2024 22:39 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 546 | $12.10 | $6,606.60 |
DisclosureSEC source: 0001593968-24-000648 · primary_01.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,948 F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares. Read SEC document |
| April 14, 2024 Filed Apr 16, 2024 01:17 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 3,463 | $11.55 | $39,997.65 |
DisclosureSEC source: 0001593968-24-000573 · primary_01.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,494 F2 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units and restricted shares. F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares. Read SEC document |
| April 13, 2024 Filed Apr 16, 2024 01:17 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 1,119 | $11.55 | $12,924.45 |
DisclosureSEC source: 0001593968-24-000573 · primary_01.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,957 F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. Read SEC document |
| April 11, 2024 Filed Apr 12, 2024 00:44 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 893 | $11.83 | $10,564.19 |
DisclosureSEC source: 0001593968-24-000570 · primary_01.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,076 F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units and restricted shares. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units & unvested restricted shares. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 19:06 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | OtherCommon Stock | 2,024 | $10.50 | $21,246.94 |
DisclosureSEC source: 0001593968-24-000556 · primary_01.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 429,413 F1 · shares: These shares have been purchased through the Company's Amended and Restated 2006 Employee Stock Purchase Plan, a "tax-conditioned plan" per Internal Revenue Code Section 423. This purchase is exempt from Section 16 of the Securities Exchange Act of 1934 regarding liabilities arising from six-month short-swing transactions in the Company's securities. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 19:36 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 546 | $16.19 | $8,839.74 |
DisclosureSEC source: 0001593968-24-000184 · primary_01.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 427,389 F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units and restricted shares. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares. Read SEC document |
| January 18, 2024 Filed Jan 20, 2024 02:08 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 4,871 | $17.39 | $84,726.17 |
DisclosureSEC source: 0001593968-24-000108 · primary_01.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 427,935 F1 · shares: Withheld for tax obligations upon vesting of restricted stock units and restricted shares. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 21:53 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 1,113 | $17.24 | $19,189.23 |
DisclosureSEC source: 0001593968-24-000102 · primary_01.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 432,806 F1 · shares: Represents shares that were sold to satisfy tax withholding obligations upon vesting of restricted stock units and restricted shares. Read SEC document |
| December 28, 2023 Filed Jan 2, 2024 21:35 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-24-000005 · primary_01.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 433,919 F1 · shares: The shares were donated to Schwab Charitable. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares. Read SEC document |
| October 27, 2023 Filed Oct 28, 2023 00:27 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 25,239 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-23-013483 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 438,919 F1 · shares: One-sixteenth (1/16) of the total number of shares subject to the restricted stock unit awards shall become exercisable at the end of each three full calendar months following the date of this action, provided that such recipient is still employed by the corporation on such dates. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares. Read SEC document |
| October 16, 2023 Filed Oct 18, 2023 01:33 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 5,015 | $37.31 | $187,109.65 |
DisclosureSEC source: 0001654954-23-013063 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 413,680 F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units and restricted shares. This does not represent a sale by the Reporting Person. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares. Read SEC document |
| October 13, 2023 Filed Oct 17, 2023 00:24 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 1,611 | $38.74 | $62,410.14 |
DisclosureSEC source: 0001654954-23-012989 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 418,695 F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units and restricted shares. This does not represent a sale by the Reporting Person. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares. Read SEC document |
| October 11, 2023 Filed Oct 13, 2023 01:44 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 1,077 | $40.17 | $43,263.09 |
DisclosureSEC source: 0001654954-23-012853 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 420,306 F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units and restricted shares. This does not represent a sale by the Reporting Person. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares. Read SEC document |
| October 02, 2023 Filed Oct 3, 2023 20:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | OtherCommon Stock | 260 | $27.67 | $7,193.55 |
DisclosureSEC source: 0001654954-23-012559 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 421,383 F1 · shares: These shares have been purchased through the Company's Amended and Restated 2006 Employee Stock Purchase Plan, a "tax-conditioned plan" per Internal Revenue Code Section 423. This purchase is exempt from Section 16 of the Securities Exchange Act of 1934 regarding liabilities arising from six-month short-swing transactions in the Company's securities. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares. Read SEC document |
| July 17, 2023 Filed Jul 19, 2023 20:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 123,811 | $51.29 | $6,349,758.56 |
DisclosureSEC source: 0001654954-23-009399 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 421,123 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.275 to $52.70, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares. Read SEC document |
| July 14, 2023 Filed Jul 17, 2023 20:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 5,099 | $48.96 | $249,647.04 |
DisclosureSEC source: 0001654954-23-009264 · section16.xml · nonDerivative · entry 3 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 544,934 F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units and restricted shares. This does not represent a sale by the Reporting Person. F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares. Read SEC document |
| July 14, 2023 Filed Jul 17, 2023 20:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 50,000 | $45.00 | $2,250,000.00 |
DisclosureSEC source: 0001654954-23-009264 · section16.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 550,033 F2 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 17. 2022. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 20:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 1,620 | $41.43 | $67,116.60 |
DisclosureSEC source: 0001654954-23-009264 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 600,033 F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units and restricted shares. This does not represent a sale by the Reporting Person. Read SEC document |
| July 11, 2023 Filed Jul 13, 2023 20:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 1,215 | $38.71 | $47,032.65 |
DisclosureSEC source: 0001654954-23-009126 · section16.xml · nonDerivative · entry 4 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 601,653 F4 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted shares. This does not represent a sale by the Reporting Person. F5 · balance_after: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares. Read SEC document |
| July 11, 2023 Filed Jul 13, 2023 20:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-23-009126 · section16.xml · nonDerivative · entry 3 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 602,868 F3 · shares: 25% of shares subject to the restricted shares awards shall vest immediately and the remaining 75% of shares will vest quarterly over the remaining 3 years. Read SEC document |
| July 11, 2023 Filed Jul 13, 2023 20:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 3,954 | $38.71 | $153,059.34 |
DisclosureSEC source: 0001654954-23-009126 · section16.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 592,868 F2 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person. Read SEC document |
| July 11, 2023 Filed Jul 13, 2023 20:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 31,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-23-009126 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 596,822 F1 · shares: 25% of shares subject to the restricted stock unit awards shall vest immediately and the remaining 75% of shares will vest quarterly over the remaining 3 years. Read SEC document |
| April 14, 2023 Filed Apr 17, 2023 20:47 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 4,921 | $28.92 | $142,315.32 |
DisclosureSEC source: 0001654954-23-004849 · section16.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 565,572 F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units and restricted shares. This does not represent a sale by the Reporting Person. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares. Read SEC document |
| April 13, 2023 Filed Apr 17, 2023 20:47 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 1,571 | $29.81 | $46,831.51 |
DisclosureSEC source: 0001654954-23-004849 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 570,493 F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units and restricted shares. This does not represent a sale by the Reporting Person. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 20:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | OtherCommon Stock | 3,000 | $2.18 | $6,553.50 |
DisclosureSEC source: 0001654954-23-004450 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 572,064 F1 · shares: These shares have been purchased through the Company's Amended and Restated 2006 Employee Stock Purchase Plan, a "tax-conditioned plan" per Internal Revenue Code Section 423. This purchase is exempt from Section 16 of the Securities Exchange Act of 1934 regarding liabilities arising from six-month short-swing transactions in the Company's securities. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 20:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 50,000 | $40.00 | $2,000,000.00 |
DisclosureSEC source: 0001654954-23-003600 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 569,064 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 17, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.07, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 23,856 | $0.00 Strike: $3.93 | $0.00 |
DisclosureSEC source: 0001654954-23-001225 · section16.xml · derivative · entry 6 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,856 shares Expires 2024-07-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 80,997 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001654954-23-001225 · section16.xml · derivative · entry 5 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 80,997 shares Expires 2025-08-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 18,958 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001654954-23-001225 · section16.xml · derivative · entry 4 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,251 Underlying: Common Stock · 18,958 shares Expires 2026-07-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 18,958 | $1.64 | $30,996.33 |
DisclosureSEC source: 0001654954-23-001225 · section16.xml · nonDerivative · entry 3 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 619,064 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 80,997 | $2.40 | $194,392.80 |
DisclosureSEC source: 0001654954-23-001225 · section16.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Exercise / conversionCommon Stock | 23,856 | $3.93 | $93,754.08 |
DisclosureSEC source: 0001654954-23-001225 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 519,109 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2023 Filed Jan 26, 2023 21:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 50,496 | $35.00 | $1,767,360.00 |
DisclosureSEC source: 0001654954-23-000874 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 495,253 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 17, 2022. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 21:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 5,534 | $28.43 | $157,331.62 |
DisclosureSEC source: 0001654954-23-000552 · section16.xml · nonDerivative · entry 3 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 545,749 F2 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units and restricted shares. This does not represent a sale by the Reporting Person. F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units and restricted shares. Read SEC document |
| January 13, 2023 Filed Jan 18, 2023 21:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 1,768 | $29.24 | $51,696.32 |
DisclosureSEC source: 0001654954-23-000552 · section16.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 551,283 F2 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units and restricted shares. This does not represent a sale by the Reporting Person. Read SEC document |
| January 13, 2023 Filed Jan 18, 2023 21:01 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 50,000 | $30.00 | $1,500,000.00 |
DisclosureSEC source: 0001654954-23-000552 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 553,051 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 17, 2022. Read SEC document |
| December 28, 2022 Filed Dec 29, 2022 02:17 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-017024 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 603,051 F1 · shares: The shares were donated to Schwab Charitable. F2 · balance_after: The amount reported includes shares subject to unvested restricted shares and unvested restricted stock units. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 00:04 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 69,690 | $25.90 | $1,804,768.90 |
DisclosureSEC source: 0001654954-22-015466 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 608,051 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $26.66, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. F2 · balance_after: The amount reported includes shares subject to unvested restricted shares and unvested restricted stock units. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 20:05 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | OtherCommon Stock | 2,217 | $2.18 | $4,843.04 |
DisclosureSEC source: 0001654954-22-013326 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 677,741 F1 · shares: These shares have been purchased through the Company's Amended and Restated 2006 Employee Stock Purchase Plan, a "tax-conditioned plan" per Internal Revenue Code Section 423. This purchase is exempt from Section 16 of the Securities Exchange Act of 1934 regarding liabilities arising from six-month short-swing transactions in the Company's securities. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| July 14, 2022 Filed Jul 15, 2022 01:22 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 2,023 | $8.00 | $16,184.00 |
DisclosureSEC source: 0001654954-22-009726 · section16.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 560,666 F1 · shares: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person. F2 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.